Top Sector Life Sciences & Health (LSH) entails a broad scope of disciplines, from pharmaceuticals to medical technology and from healthcare infrastructure to vaccination. To realise its mission – vital citizens in a healthy economy - the Top Sector builds on the strengths of the Dutch LSH sector to address the biggest societal challenges in prevention, cure and care. By funding multidisciplinary public-private partnerships (PPPs) the Top Sector aims to facilitate innovation. Here we give an overview of  a number of funded R&D projects by Top Sector LSH. The page is updated continuously.

150 projects

  • “Sticky” peptides to fight antimicrobial resistance

    “Sticky” peptides will prevent that by 2050 antimicrobial resistance will be responsible for about 10 million deaths annually.
  • Resolving liver fibrosis with nutritional and therapeutic interventions.

    Obtaining more insight into the processes involved in hepatic fibrosis development caused by non-alcoholic steatohepatitis. .
  • Project MinE: unraveling genetic basis of ALS by large-scale genetic sequencing

    To understand the genetic basis of ALS, Project MinE aims to sequence 22,500 DNA profiles.
  • Mode of action of candidate drugs for treatment of Cystic Fibrosis

    Successful collaboration has led to better insight into mechanisms of action for new drugs in development for people with Cystic Fibrosis.
  • Use of NK cells to stimulate the chicken immune system for better protection against pathogens

    Enhance the development of the chicken innate immune system by stimulating chicken natural killer cells.
  • Patient-friendly therapeutic for the treatment of Amyotrophic Lateral Sclerosis

    TW001 has the potential to significantly slow down ALS disease progression and to improve the patient’s quality of life.
  • A new class of medicine for Ulcerative Colitis

    Studying the efficacy of a new class of medication, kinase inhibitors, to treat ulcerative colitis patients.